Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Mitchell_H._Gold
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
gptkb:cancer
immunotherapy autoimmune diseases |
| gptkbp:foundedYear |
2015
|
| gptkbp:fullName |
gptkb:Alpine_Immune_Sciences,_Inc.
|
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALPMY
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:numberOfEmployees |
approximately 100
|
| gptkbp:stockSymbol |
gptkb:ALPMY
|
| gptkbp:tradedOn |
gptkb:OTC_Markets
|
| gptkbp:website |
https://www.alpineimmunesciences.com/
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma
|
| gptkbp:bfsLayer |
5
|